Adlai Nortye Ltd. Sponsored ADR (ANL) vs Kura Oncology, Inc. (KURA)

Adlai Nortye Ltd. Sponsored ADR and Kura Oncology, Inc. are both Biotechnology companies. Adlai Nortye Ltd. Sponsored ADR and Kura Oncology, Inc. are of similar size ($977.7M and $929.7M). Across the 8 metrics below, Adlai Nortye Ltd. Sponsored ADR leads on 8 and Kura Oncology, Inc. on 0.

Valuation

Metric ANL KURA Biotechnology median
P/E — n/m 7.88
P/S — 12.45 11.47
P/B n/m 19.85 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m 5.86 10.73
Earnings yield — (31.15%) (28.84%)
Free cash flow yield 0.00% (12.21%) (23.03%)

Profitability

Metric ANL KURA Biotechnology median
Gross margin — 99.35% 65.16%
Operating margin — (411.90%) 0.00%
Net margin — (384.30%) 0.00%
Free cash flow margin 0.00% (152.06%) 0.00%
Return on equity 0.00% (167.71%) (57.72%)
Return on assets 0.00% (46.73%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ANL KURA Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 31.48% (57.43%) —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric ANL KURA Biotechnology median
Debt to equity 0.12 0.20 0.00
Current ratio 9.55 4.73 4.73
Net debt to EBITDA (0.05) 2.11 0.96

Dividend

Metric ANL KURA Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric ANL KURA Biotechnology median
Market cap 929.70m 977.67m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack